Observational
12
1
1
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (12)
Real-World Treatment Study of Soliris (Eculizumab)
Clinical Study of 18F-FAPI-RGD in Ovarian Cancer
Arthroscopy of the Temporomandibular Joint. On Jaw Mobility, Pain and HRQoL
Adenovirus Infection in Children With Autoimmune Hepatitis
Tracking CF Lung Disease Through the Early Years: Utility of the LCI
Targeted Next Generation Sequencing for the Efficacy of Trastuzumab Neoadjuvant Chemotherapy in Breast Cancer
Stapler Post-market Observational Study
Use of FFR-CT in Stable Intermediate Chest Pain Patients With Severe Coronary Calcium Score
Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma
DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines
Progression of Renal Amyloidosis of FMF and Relation to Serum SAA Level
Atypical Antipsychotics in Improvement of Quality of Life in Bipolar Disorder